Yarrow Bioscience Inc (YARW) Stock Forecast
YARW analyst forecast
as of October 18, 2026- Analyst consensus
- Strong buy 5.00 / 5 from 3 analysts
- Price target
- $57.00 average of analyst targets
- Upside to target
- +211.3% from the latest close
- Next earnings
- November 5, 2026
- 52-week range
- $16.40 – $46.15
YARW analyst ratings
3 analystsNumber of analysts at each rating.
YARW price target
The average of analyst 12-month price targets compared with the latest close and the 52-week range.
YARW earnings per share estimates
| Period | Average | Low | High | Year ago | Growth | Analysts |
|---|---|---|---|---|---|---|
| Current quarter (Sep '26) | −$0.32 | −$0.32 | −$0.32 | — | — | 1 |
| Current fiscal year (2026) | −$1.45 | −$1.45 | −$1.45 | — | — | 1 |
| Next fiscal year (2027) | −$1.65 | −$1.65 | −$1.65 | −$1.45 | −13.8% | 1 |
Consensus EPS estimates; growth compares the average estimate with the year-ago EPS.
YARW revenue estimates
| Period | Average | Low | High | Growth | Analysts |
|---|---|---|---|---|---|
| Current quarter (Sep '26) | $0 | $0 | $0 | — | 1 |
| Current fiscal year (2026) | $0 | $0 | $0 | — | 2 |
| Next fiscal year (2027) | $0 | $0 | $0 | 0.0% | 2 |
YARW EPS: reported and forecast
Fiscal years; "E" marks estimates, the line shows the range from the lowest to the highest estimate.
YARW EPS estimate revisions
| Period | 90 days ago | 60 days ago | 30 days ago | 7 days ago | Now | Change (90 d) | Revisions (30 d) |
|---|---|---|---|---|---|---|---|
| Current quarter (Sep '26) | $0.00 | $0.00 | $0.00 | −$0.34 | −$0.32 | — | 0 up · 0 down |
| Current fiscal year (2026) | $0.00 | $0.00 | $0.00 | $0.00 | −$1.45 | — | 0 up · 0 down |
| Next fiscal year (2027) | $0.00 | $0.00 | $0.00 | $0.00 | −$1.65 | — | 0 up · 0 down |
How the consensus EPS estimate changed over the last 90 days, and how many analysts raised or lowered it in the last 30 days.
YARW earnings surprises
What analysts expect from YARW
3 analysts cover Yarrow Bioscience; their consensus rating is strong buy (5.00 on a 1–5 scale, where 5 is a strong buy). The average price target is $57.00, 211.3% above the latest close of $18.31. Analysts expect earnings of −$1.45 per share for 2026. For 2027 the average estimate is −$1.65 per share.
Related: YARW income statement, YARW key metrics, YARW chart. See the YARW stock overview for the latest quote and news.
YARW forecast FAQ
What is Yarrow Bioscience's price target?
The average analyst price target for Yarrow Bioscience is $57.00, 211.3% above the latest close of $18.31.
Is Yarrow Bioscience a buy, hold or sell?
Of 3 analysts covering Yarrow Bioscience, 3 rate it a strong buy, 0 a buy, 0 a hold, 0 a sell and 0 a strong sell, a consensus of strong buy. Ratings are opinions, not a recommendation from Quotelinks.
What is Yarrow Bioscience's EPS forecast?
Analysts forecast −$1.45 per share for 2026 (range −$1.45 to −$1.45); for 2027 the estimate is −$1.65.
When does Yarrow Bioscience report earnings?
Yarrow Bioscience is expected to report results for the quarter ending September 30, 2026 on November 5, 2026.